| 10046000 |
Use of 2-methylene-19-nor-(20S)-1α,25-Dihydroxyvitamin D3 to treat and prevent secondary hyperparathyroidism in a subject having renal failure |
Hector F. DeLuca, Lori A. Plum, Margaret Clagett-Dame |
2018-08-14 |
| 9717744 |
Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to prevent secondary hyperparathyroidism or the symptoms thereof |
Hector F. DeLuca, Lori A. Plum, Margaret Clagett-Dame |
2017-08-01 |
| 9205096 |
Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism |
Hector F. DeLuca, Lori A. Plum, Margaret Clagett-Dame |
2015-12-08 |
| 9034853 |
Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism |
Hector F. DeLuca, Lori A. Plum, Margaret Clagett-Dame |
2015-05-19 |
| 8114393 |
Methods and compositions for phosphate binding |
Hector F. DeLuca, Katarzyna M. Barycka, Lori A. Plum, Margaret Clagett-Dame |
2012-02-14 |
